New Eye Tech Is Booming For Alcon, Stock Soars

Benzinga
2025/11/13

Eye care firm Alcon Inc. (NYSE:ALC) on Tuesday reported third-quarter sales of $2.59 billion, up 6% year over year (up 5% constant currency), marginally missing the consensus of $2.60 billion.

  • ALC shares are climbing with conviction. View the charts here

“As expected, we saw encouraging topline growth in the third quarter, driven by strong acceleration in equipment,” said David J. Endicott, Alcon’s CEO. “Unity VCS is gaining traction across key markets, and our orderbook remains strong. With PanOptix Pro resonating well with surgeons and early uptake of Tryptyr showing promise, we’re laying the groundwork for a solid 2026.”

Alcon reported adjusted earnings of 79 cents, beating the consensus of 76 cents.

Also Read: Activist Investor Seeks Strategic Overhaul At Contact Lens Maker Cooper, Suggests Merger With Bausch + Lomb

Surgical net sales, which include implantables, consumables, and equipment/other products, were $1.42 billion, representing a 6% increase on a reported basis and a 5% increase on a constant currency basis, year over year.

Vision Care net sales, which include contact lenses and ocular health products, were $1.2 billion, representing a 7% increase on a reported basis (+5%).

Core operating income was $523 million, representing a 4% increase and a 2% constant currency (cc) increase.

The core operating margin decreased by 0.4 percentage points to 20.20% in the current year period, which included incremental tariffs, sales and marketing investments behind new product launches, and increased investment in R&D. This decrease was partially offset by manufacturing efficiencies and price increases.

Outlook

Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.06.

The company maintained its 2025 sales guidance of $10.3 billion to $10.4 billion, versus the consensus of $10.39 billion.

Core operating margin is expected to be between 19.5% and 20.5%.

ALC Price Action: Alcon shares were up 4.91% at $81.15 at the time of publication on Wednesday, according to Benzinga Pro data.

Read Next:

  • ‘Wanted To Show The True Elon,’ Author Andrew Sorkin Says About 2023 DealBook Summit Interview With Tesla CEO

Photo via Shutterstock

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10